March 23rd, 2015

Information Solutions @ Elsevier

Alexander van Boetzelaer, MD Elsevier R&D Solutions

Digital Innovators’ Summit – Berlin

The future of professional information

From print… …to electronic databases…

…to electronic decision tools

RELX is a world leading provider of information solutions for professional customers across industries

We help scientists make new discoveries,lawyers win cases, doctors save lives,

corporations build commercial relationships,insurance companies assess risk, and government and financial institutions

detect fraud

Transformation from print to electronic

4

-5-7%

+6-7%

+5-6%

14%14%17%15%

12%13%

15%15%15%

66%12%12%14%14%

14%

59%

14%

50%

17%

48%

15%

12%13%12%

64%

15%

61%

15%

63%

15%

Electronic Face to face Print

22% 22%28% 30% 32% 35% 37%

48% 50%59% 61% 63% 64% 66% 66%

14% 14%12% 12% 12%

13% 12%

15%17%

14% 14% 15% 15% 15% 18%64% 64% 60% 58% 56% 52% 51%

37% 33%27% 25% 22% 21% 19% 16%

20132012201120102009200820072006200520042003200220012000

RELX revenues by format

2014

Science Technology & Medical division of RELX

Founded >130 years ago

Revenues: $3.1bn 2014 (~70% electronic)

Customers in >180 countries (1/3 North America, 1/3 Europe, 1/3 RoW)

14,800 FTEs: ~6,800 employees in 25 countries; ~8,000 outsourced FTEs

Elsevier today – providing information and tools to help customers improve scientific and healthcare outcomes

Provides universities, governments, and research institutions with the resources and insights to improve institutional research strategy, management, and performance.

Supports corporate and academic researchers and professionals to accelerate and improve R&D decisions and outcomes, specifically in the areas of drug development and design engineering

Helps medical professionals apply trusted data and sophisticated tools to make better clinical decisions, deliver better care, and produce better healthcare outcomes.

Helps educate highly-skilled, effective healthcare professionals, using the most advanced pedagogical tools and reference works.

Publishes over 2,200 online journals & over 10,000 e-books

ElsevierResearch

Intelligence

ElsevierR+D Solutions

ElsevierClinical

Solutions

ElsevierEducation.

Online Journals &

eBooks

CONTENT SOLUTIONS

Lead the way in advancing science, technology and health

Mission & strategic priorities

• Increase content volume and quality• Expand content coverage• Increase content utility• Combine content with analytics and technology• Drive operational efficiency and effectiveness

Two examples

1. Research: content-centricity → researcher-centricity

2. Drug discovery: selling the value

9

We serve the world of research

“Enabling Research” “Doing Research” “Sharing Research”

Search, discover, read, review

Synthesize/AnalyzeExperiment

Recruit/evaluate researchers

Secure Funding

Manage facilities

Publish anddisseminate

Manage Data Promote

Commer-cialize

Collaborate & network

Establishpartnerships

?

Develop Strategy

Have impact

!$

7m+ researchers worldwide• New discoveries• Improve society• Career

Researchers

4000+ institutions worldwide• Funding• Reputation• Impact on

societyInstitutions

Goals (impact)

READER EDITOR

AUTHOR

REVIEWER

TEACHER

COLLABORATOR

RESEARCHER

We interact with researchers in their different roles through our various Elsevier products

READER

REVIEWER

AUTHOR

EDITOR

TEACHER

But platforms serving the SAME Researcher are designed as silos

Making our platforms talk to each-other, to deliver more than just the obvious for the researcher in all the varying roles

JournalsA&I

3rd partypublic

UnstructuredProprietary datae-books

StructuredProprietary data

Elsevier & 3rd party platforms and tools

singleaccess & entitlement

READER EDITOR

AUTHORREVIEWER TEACHERCOLLABORATOR

RESEARCHER

12

Content

User

Content

Analytics

ContentCentric

Solutions

NetworkDriven

Solutions

ResearcherCentric

SolutionsTechnology

Adding more value by going from content to networks

ContentCentric

Solutions

ResearcherCentricSolution

AuthorCentric

Solutions

Usage alerts evolving into a research dashboard

20132013 20142014

Usage Alert My Research Dashboard

Two examples

1. Research: content-centricity → researcher-centricity

2. Drug discovery: selling the value

17

Target ID & Valid Pre-clinical Clinical Post-

LaunchLead ID & Valid

Target Lead (drug)

Questions addressed

How do we monitor the commercialized leads for adverse events?

How do we assess and prioritize the identified leads for safety, delivery and efficacy?

What leads can hit the identified targets?

What are the potential targets related to the disease?

We have developed an integrated set of solutions thatseamlessly address the drug discovery workflow

Selling the value

Input & Output

Outcomes & Income

Information Manager

Researcher

Board Level

Usage

Success / Business Impact

• (Enriched) content is still king

• Go To Market too often underestimated

• “Over-index” on external focus and execution

Some lessons learned

Thank you